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Abstract
One of the major difficulties in evaluating the efficacy of deep brain stimulation (DBS), or understanding its mechanism, is
the need to distinguish the effects of stimulation itself from those of the lesion inevitably created during surgery. Recent
work has shown that DBS of the subthalamic nucleus in Parkinson’s disease greatly reduces the time it takes the eyes to
make a saccade in response to a visual stimulus. Since this saccadic latency can be rapidly and objectively measured, we
used it to compare the effects of surgery and of stimulation. We used a saccadometer to measure the saccadic latencies of 9
DBS patients (1) preoperatively, (2) the day after insertion of subthalamic nucleus electrodes, (3) three weeks later, prior to
turning on the stimulator, and (4) after commencement of stimulation. Patients were on their anti-Parkinsonian medication
throughout the study. It revealed an entirely unexpected and puzzling finding. As in previous studies an amelioration of
symptoms is seen immediately after surgery, and then a further improvement when finally the stimulator is turned on, but
in the case of saccadic latency the pattern is different: surgery produces a transient increase in latency, returning to baseline
within three weeks, while subsequent stimulation reduced latency. Thus the differential effects of electrode placement and
stimulation are completely different for saccades and for more general motor symptoms. This important finding rules out
some over-simple interpretations of the mechanism of DBS, and needs to be taken into account in future attempts at
modelling the neurophysiology of DBS.
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Introduction
High frequency stimulation of the subthalamic nucleus (STN) is
a surgical procedure indicated for the treatment of advanced
Parkinson’s disease (PD) that has become resistant to other
interventions and medication. It is effective for bradykinesia,
rigidity, on-off effects, and tremor [1,2,3] and by virtue of dose
reduction can ameliorate levodopa-induced dyskinesias [4,5]. Its
effects are long lasting [6,7,8]. Apart from its therapeutic benefits
in alleviating the symptoms of PD, deep brain stimulation (DBS) of
the STN has also been shown previously to produce consistent,
large and robust reductions in saccadic latency [9,10,11,12], i.e.
the time taken to initiate an eye movement to look at a novel visual
target [10,11]. Since with modern miniaturised, non-invasive
equipment, several hundred individual measurements of saccadic
latency (saccadometry) can be made in a matter of minutes, this
can potentially provide a more objective and qualitative way of
evaluating the effects of DBS. Further benefits of saccadometry are
that it provides an internationally-standardized task, and also that
we have a widely accepted and applied model, LATER, that
enables one to relate the findings to the presumed underlying
neural decision mechanisms (see for instance [13,14,15,16]).
The mechanisms that underlie the effects of deep brain
stimulation (DBS) in PD remain mysterious: it has been argued by
some that it increases neural activity, by others that it decreases
activity,andbystillothersthatitproducesmorecomplexeffectssuch
as interference with pathological rhythms [12,17,18,19,20,21,22].
An example of this complexity is the common experience that there
is an improvement in Parkinsonian symptoms immediately after
insertion of stimulator leads, despite the stimulator not yet being
active [23,24], in other words that the operation itself causes
amelioration. This is a transient phenomenon and disappears over
a period of days to a few weeks, to be replaced by a more sustained
therapeutic effect when the stimulator is switched on [1,2,7,25,
26,27].
Saccadometry therefore seemed to us a good way of trying to
compare changes in behaviour due to the stimulation itself from
those due to the lesion that is inevitably created by the insertion of
the stimulator leads at the time of surgery, more precisely and
objectively than conventional clinical evaluation, which is
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32830necessarily imprecise and subjective. As we report, what we found
was unexpected and more than a little puzzling: that the huge
effects of electrode placement and electrical stimulation on latency
do not correspond in direction with the normal sequence of
clinical amelioration. Whereas from a clinical point of view both
the surgery of electrode placement, and the actual turning on of
the current both reduce the clinical manifestations of the
condition, surgery makes saccadic latency worse, but the eventual
stimulation makes it much better. This surprising finding rules out
some over-simple interpretations of how DBS works.
Materials and Methods
Patients
A total of nine patients underwent bilateral STN DBS, seven
male and two female, mean age 64.4 years (range 38–73). Mean
disease duration prior to DBS was 9.4 years (range 4–14). The
indication for surgery was either severe motor fluctuations with
dyskinesias (6 patients) or treatment resistant tremor (3 patients).
Of the patients with treatment resistant tremor, one also had
motor fluctuations and another had medication intolerance. See
table 1 for more details. This study was approved by the
Cambridge Research Ethics Committee and was conducted at
Addenbrooke’s Hospital, Cambridge, UK. All participants gave
their written informed consent after the procedures had been
explained to them.
Clinical assessments
Patients were assessed by an experienced neurologist (PB) using
the Movement Disorder Society - Unified Parkinson’s disease
rating scale (MDS - UPDRS) parts III (motor signs of Parkinson’s
disease) and IV (motor complications, dyskinesias and motor
fluctuations), as well as the Hoehn and Yahr (HY) staging system.
Recording saccadic eye movements
Visually guided horizontal saccades were recorded using a
miniaturised infra-red 1 kHz saccadometer, low-pass filtered at
250 Hz with 12 bit resolution [28]. Patients wore the device on
their head, secured by an elastic strap and resting on the bridge of
the nose; three built-in low-power lasers projected red 13 cd m
22
spots subtending some 0.1 degrees in a horizontal line in the
midline at 610 degrees [29]. Because the stimuli move exactly
with the head, no head-restraint is necessary: sessions were
therefore comfortable for the PD patient, especially for those
suffering with severe dyskinesias.
In each trial the central fixation target was displayed for a
random fore-period of 1.0–2.0 s. It then appeared to jump to one
of the two peripheral positions, chosen at random, and remained
illuminated until 200 ms after the end of the saccade. Participants
were instructed to follow the target with their eyes as it moved. A
single experimental run consisted of twenty calibration trials
followed by 200 experimental trials, and lasted less than
10 minutes; aberrant records contaminated by excessive head
movement and blinks were automatically removed by the
software, which also determined the saccadic latency using a
saccade-detection algorithm based on velocity and acceleration.
Surgical procedure
Prior to surgery a 3 Tesla magnetic resonance imaging (MRI)
scan was obtained for each patient and checked to confirm good
visualisation of the target anatomy. A Leksell stereotactic frame
(Elekta, Sweden) was secured in position parallel to the AC-PC
plane under local anaesthesia. A CT scan obtained with the frame
in position was fused with the MRI scan using Framelink planning
software (Medtronic, UK). Target co-ordinates were obtained for
the subthalamic nucleus (STN), using direct anatomical targeting
from the 3T MRI data set, and the stimulator lead (3389,
Medtronic) advanced to target. The system was connected to a test
stimulator set to deliver 60 ms pulses at 130 Hz. Neurological
examination was performed as the stimulation current was slowly
increased. Once satisfactory stimulation was confirmed the lead
was secured in position and the process repeated on the opposite
side. No electrode in this series was repositioned during surgery. A
repeat CT scan was obtained and fused with the preoperative
MRI scan to confirm the correct targeting. An example is shown
in figure 1 where the leads are seen superimposed on the MRI
image. The frame was then removed and under general
anaesthesia the stimulator leads were tunnelled subcutaneously
to a subclavicular pocket where they were connected to a Kinetra
stimulator (Model 7428, Medtronic, UK).
The patient returned to the ward with the system remaining
switched off. The patient was discharged on their original
pharmacotherapy. Once they had recovered from surgery (three
to four weeks postoperatively) the system was activated and titrated
to clinical response in order to optimise the therapeutic effect.
Protocol
All patients underwent saccadometry (a) preoperatively, (b)
24 hours postoperatively, (c) three to four weeks postoperatively,
immediately prior to switching on the stimulator, and (d) following
switch-on. General anaesthetic was administered only for the
‘‘tunneling’’ of the leads, for less than an hour. All patients were
receiving their normal, uninterrupted, dopaminergic medication
throughout this period, but because of the clinical priorities in this
context, it was impossible to arrange for measurements to be made
at precisely equivalent times after medication is taken. However, a
previous study of combinations of medication and DBS [30]
showed that medication per se had no significant effect of median
latency, and if anything reduced the effects of DBS on latency. We
did not measure latencies when the current was switched off again
after ‘stimulation on’ because of the obvious ethical issues: this
point had already been checked, and thoroughly confirmed, in
previous studies [10,11].
Statistical analysis
The Kolmogorov-Smirnov two-sample statistic K-S2 [31], was
used for comparing observed distributions, and one-sample
statistic K-S1 for comparing observed with theoretical (LATER)
distributions (http://www.cudos.ac.uk/later.html). Best-fit estima-
tions of the LATER parameters were obtained by minimisation of
the K-S1 statistic; no data set deviated significantly from the
model. Since latency distributions are skewed, median latency
(which is the reciprocal of the LATER m parameter) was used as
the preferred characteristic parameter. For comparing means of
derived parameters in single subjects, the Student paired two-
tailed t-test (exactly equivalent to repeated measures ANOVA) was
used, having first confirmed compatibility with normal distribu-
tions of the parameter using the Shapiro-Wilk test. For
comparisons between different timepoints, the paired two-tailed
t-test was used for saccadic latencies, while the nonparametric sign
test was used for clinical rating scores.
Results
The preoperative and postoperative MDS-UPDRS parts III
and IV scores and Hoehn and Yahr stages of all nine patients are
shown in Table 1. The mean pre–operative UPDRS part III score
was 37.0 (range 20–52) and the mean preoperative part IV score
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e32830was 8.1 (range 1–13). One patient was HY stage 1, one stage 2,
four stage 3, and three stage 4.
Even though they received no stimulation in the immediate
postoperative period, all nine patients reported a symptomatic
improvement as a result of the electrode placement, reflected in
improvements in the UPDRS part III score. The mean UPDRS
III at 24 hours postoperatively was 31.3 (range 13–45). The mean
reduction in UPDRS III was 5.7 (range 1–11) and was significant
with p=0.002 (two sided sign test). This beneficial effect decayed
away over the next three weeks.
Following switch-on of the stimulator there was substantial
clinical improvement. UPDRS III fell to a mean of 24.8 (range 7–
36), with a mean reduction of 12.2 (range 7–19), p=0.002 (two
sided sign test). UPDRS IV fell to a mean of 1.2 (range 0–2), mean
reduction 6.9 (range 0–12), p=0.004 (two sided sign test). Three
patients’ HY stage improved by one point, the other six being
unchanged. Table 2 lists the actual coordinates of the electrode
lead tips, obtained by fusing the postoperative CT with the original
MRI scan, together with the stimulator parameters (voltage,
frequency, pulse width, and contacts used), for each patient.
The median saccadic latency for each patient at each time-point
is shown in Figure 2, and the means of these latencies, averaged
over all nine patients at each time-point and relative to the
baseline pre-operative value, are shown in Figure 3; Table 3
summarises all the saccadic parameters.
As can be seen from figure 2, for every patient the median
latency is higher 24 hours postoperatively than preoperatively.
The mean rise in latency from baseline is 71 ms, and is significant
with p=0.02 (paired two-tailed t-test). Then – like the therapeutic
benefit – this change in latency declines over the subsequent three
weeks, in eight of the nine patients. At three weeks postoperatively,
prior to switch-on, the mean latency is just 6 ms above baseline
Figure 1. Confirmation of lead position: Postoperative thin
slice CT windowed to show only the radio-dense leads (bright
white spots) and fused to the preoperative T2 weighted MRI
scan.
doi:10.1371/journal.pone.0032830.g001
Table 2. Actual coordinates of lead tips, and stimulation parameters, for each patient.
Case Side Lead tip actual coordinates relative to mid AC-PC Stimulation parameters
Anterior (y) Lateral (x) Vertical (z) Contacts Volts Width Freq
1L21.8 210.4 24.0 12,22 3.5 60 130
R 22.7 11.6 24.0 42,52 3.0 60 130
2L22.7 212.0 24.5 02,12 2.0 60 130
R 22.7 11.6 22.2 5+,72 2.0 60 130
3L22.4 27.6 24.5 12 1.6 60 200
R 23.8 9.6 24.5 72 3.5 60 200
4L25.5 212.0 24.4 22 1.5 60 130
R 23.2 11.1 24.4 52 1.5 60 130
5L22.4 210.2 24.9 22,32 1.8 60 130
R 21.8 14.9 22.8 42 2.0 60 130
6L22.5 28.9 24.3 12 2.0 60 130
R 23.7 9.0 24.0 52 2.0 60 130
7L21.4 212.3 23.7 3+ 1.4 60 130
R 21.4 12.2 24.2 5+ 1.5 60 130
8L23.2 212.0 24.8 12 2.5 60 130
R 24.0 11.7 25.7 72 2.5 60 130
9L23.1 214.6 22.2 22 2.0 60 130
R 24.9 10.3 23.4 52,62 2.0 60 130
L=left lead, R=right lead; mid AC-PC=midpoint of line between anterior and posterior commisures.
doi:10.1371/journal.pone.0032830.t002
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e32830and the difference from baseline is no longer significant (p=0.17,
paired two-tailed t-test).
Following switch-on, in every case the latency decreases. Mean
latency falls from 6 ms above baseline to 39 ms below. This is a
highly significant change (p=0.003, paired two-tailed t-test), and
the difference from baseline after switch-on is also highly
significant (p=0.008, paired two-tailed t-test). Despite the wide
variation in baseline latency, the pattern of changes over time was
identical for all but one of the patients: a rise in latency
postoperatively, a return to preoperative baseline values at three
weeks, and then a fall in latency on switching on the stimulator.
The exception was patient 5 (Figure 2), for whom latency rose
slightly rather than falling over the post-operative period, before
switch-on. Unlike ordinary measurements of mean latency with a
Figure 2. Median saccadic latency for each patient at the four time points. Black=pre-operative, red=24 hrs post-operatively with
stimulation off, blue=3 weeks after operation with stimulation off, and green=immediately after switch on of stimulator.
doi:10.1371/journal.pone.0032830.g002
Figure 3. Median saccadic latency averaged over all nine patients, relative to the baseline, preoperative value; error bars show 1
S.E. Group comparisons between timepoints are illustrated at the top (* p,0.05, ** p,0.01).
doi:10.1371/journal.pone.0032830.g003
Eye Movements and Deep Brain Stimulation
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e32830much smaller number of trials, with saccadometry differences of
latency of the sizes reported here can be statistically extremely
significant. One of the main purposes of saccadometry is to gather
enough data that not only do small differences become highly
significant, but that the shape of the distribution itself can provide
important information about the underlying neural processes. An
example is one of the very first papers in this area, on the effects of
sedative doses of anesthetic: [32] reporting SEs across six subjects
of around 4 msec.
Discussion
The shortening effect of STN DBS on prosaccadic latency has
been previously documented [10,11] and the data from this study
reinforce these earlier results. That lead insertion alone can cause
a transient improvement in symptoms, often termed ‘stunning’, is
an equally well-established phenomenon, and can be seen clearly
in our dataset as a small but significant fall in the UPDRS III score
24 hours after lead insertion, in the absence of stimulation. The
efficacy and reliability of STN DBS in treating PD is very well
established, and the larger fall in UPDRS III when the stimulator
is switched on, as well as improvements in UPDRS IV and in some
cases in HY stage, are entirely as expected. The novel finding in
this paper is a very surprising one: that whereas DBS surgery and
DBS stimulation both ameliorate the clinical signs of PD, the very
large effects of DBS stimulation on saccadic latency are opposite in
direction to what is seen as the result of surgery alone.
Certain anaesthetic drugs can affect saccadic latency and it is
important to minimise the potential confounding effect they might
have on postoperative saccadic data. In this group of patients,
general anaesthesia was administered only for the tunnelling of the
leads and insertion of the stimulator battery, for less than an hour,
and the first postoperative measurements were made after a gap of
24 hours; it is very unlikely that significant residual effects of the
anaesthetic would remain. The effects of small doses of volatile
anaesthetics on saccadic latency distributions have already been
quite thoroughly documented by Carpenter and colleagues
[32,33,34].
The anatomical co-localisation of lesion and stimulation is an
important consideration when trying to make sense of these
findings. One problem is that the tissue disturbance and oedema
caused during implantation, which one assumes to be the cause of
the temporary lesioning effect, cannot be localised to a particular
point such as the lead tip - it will affect the whole tract of the lead
including the region around all four of its electrical contacts. Since
none of the leads in this study were repositioned during surgery,
the region of stimulation must be along this line, i.e. the region
stimulated will co-localise with part of the area affected by oedema.
In terms of the relative position of stimulation and oedema the
variable quantity anatomically will be how long a section of lead
there is deep to the area of stimulation. How important this is, we
do not know. Table 2 lists the details of which contacts were used
for stimulation in these patients (contacts 0,1,2,3 are on the left
lead, and 4,5,6,7 on the right, with numbers 0 and 4 being closest
to the lead tips). Use of higher numbered contacts means a greater
distance between the lead tip and the contact used for stimulation;
in this (admittedly small) group of patients we could discern no
obvious pattern with respect to the magnitude of the lesion effect.
What might these findings imply about the underlying
mechanism of STN DBS? At present we have really very little
idea how deep brain stimulation works. Even the most
fundamental question - does DBS essentially cause excitation or
inhibition? – is currently controversial, with apparently conflicting
results from different studies [12,18,19,20,21,22]. Some of this
confusion may be due to uncertainty about exactly what neurons
DBS is acting on. Depending on the magnitude of the stimulating
current, activation of neural elements may occur over distances of
millimetres [19] and is therefore almost certain to stray outside the
bounds of the nucleus, whose volume, in humans, is only some
240 mm
3 [18]. As threshold current densities are lower for axons
than for cell bodies, there is a greater likelihood of stimulating
afferents to the STN (which are predominantly inhibitory) than the
neurons of origin of the efferent excitatory pathways to substantia
nigra pars reticulata (SNr) and globus pallidus internus (GPi). In
addition, the neurons may respond to continual electrical
stimulation with depolarisation block [19,35], and there may be
transmitter depletion [36], or the depressant effects of adenosine
released from stimulated astrocytes [37]. Correspondingly, there is
far from universal agreement about how STN DBS achieves its
therapeutic effect [17,38,39,40,41]. An obvious interpretation of
the beneficial changes in parkinsonism that occur as a result of
electrode placement, and again after stimulator switch-on, is that
both placement and stimulation are having similar effects on the
STN, a functional impairment rather than enhancement. It can
thus be viewed as analogous to subthalamotomy, which, although
not often practised for fear of causing hemiballism, is therapeutic
in PD [42], improving bradykinesia through reduced excitation of
GPi and SNr.
Such an interpretation assumes that the lesions created by
electrode penetration must reduce neural activity, but this is not
necessarily true. Disruption of the afferent inhibitory projections to
the STN could lead to an increase in its activity. Furthermore, the
essentially negative effects of the associated neuronal destruction
may also be accompanied by transient excitation because of
increased leakage current in damaged dendrites of neurons whose
somata remain intact. Given that dendritic fields, at least in rats
[43] can extend over half the nucleus, this could be a functionally
widespread effect. Furthermore, one must also take into account
the fact that during insertion the electrode will be causing similar
damage – again, possibly with a mixture of positive and negative
effects – in distant structures with not very direct influence on the
subthalamus, that may nevertheless have a functional relationship
either with the initiation of saccades or with more general aspects
of behaviour. An obvious possibility is frontal cortex, though in
this study care was taken to ensure that the electrode track did not
pass through either the frontal or supplementary eye fields. At
deeper levels, the electrode will necessarily pass through the
internal capsule and part of the thalamus, and may also influence
the projection from the mediodorsal thalamus to the frontal eye
fields [44] though passage through this region does not normally
appear to evoke any obvious motor signs, it would clearly be
desirable to undertake a systematic study of possible effects on
Table 3. Saccadic LATER parameters (mean 6 SE) and
median latency, averaged over the nine patients.
Pre –op 24 hrs 3 weeks Stim On
m (reciprocal median
latency) (s
21)
4.0560.39 3.4160.40 3.9360.37 4.7560.42
s (SD of main
distribution) (s
21)
1.1460.06 1.0060.07 1.0560.07 1.1360.08
sE (SD of early
distribution) (s
21)
4.7060.43 4.1960.38 4.4660.34 3.4960.63
Median Latency (ms) 270 341 276 231
doi:10.1371/journal.pone.0032830.t003
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electrode advancement.
These afferent pathways, and the STN itself, are divided into
zones corresponding to different kinds of input [45], and to a
certain extent to the two major outputs of the STN, SNr (that in
turn influences saccades through the superior colliculus) and GPi
(that influences other kinds of movements through its thalamo-
cortical projection) [46,47]. This may perhaps provide an
explanation for the otherwise puzzling difference that we have
observed between saccadic latency and amelioration of PD
symptoms. If the result of both electrode placement and
stimulation is a complex balance between excitatory and inhibitory
effects, then it is quite possible that this balance is different in each
case as between oculomotor and more general effects. In addition,
the STN sends a powerful glutamatergic projection to the
substantia nigra pars reticulata [48,49,50] which generates
disinhibition of the superior colliculus [51], part of a pathway
descending from the cortex via the caudate nucleus and globus
pallidus, that plays an important role in the initiation of saccades;
these pathways are very likely anatomically distinct, and might
again contribute to a different balance of excitation and inhibition
in the two cases.
Clearly more detailed investigation is needed at the time of
electrode insertion, including systematic exploration of different
levels of stimulation that will produce different degrees of current
spread. The STN is a mysterious structure, and exactly what these
procedures are doing to it is equally mysterious. The fact that it
has a rather central role specifically in saccadic control, and that
saccadometry can generate relatively reliable quantitative data in a
short period of time under clinical conditions, provides a valuable
tool that may help elucidate how the function of the STN is
modified in DBS.
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